Health Systems Saw Suicides, Attempts Decrease After Implementing “Zero Suicide Model,” Study Finds

The AP (4/7, Johnson) reports a study found that healthcare “systems can reduce suicides through patient screening, safety planning and mental health counseling.” The “Zero Suicide Model,” developed in 2021 at Detroit-based Henry Ford Health, focuses on “collaborating with patients to reduce their access to lethal means such as firearms and then following up with treatment.” For all of 2009, “the health system saw no suicides among patients. The researchers then studied what happened when a different health system, Kaiser Permanente, adopted the program in four locations from 2012 through 2019.” They found that “suicides and suicide attempts fell in three of the locations, while the fourth maintained a low rate of suicides and attempts.” The study was published in JAMA Network Open.

Related Links:

— “Suicides and attempts fall in health systems implementing the ‘Zero Suicide Model,’ study finds,”Carla K. Johnson, AP, April 7, 2025

Discrimination Boosts Risk Of Depression And Anxiety, Study Says

HealthDay (4/4, Thompson ) reported that “more than half of Americans have experienced some such form of discrimination, and this mistreatment dramatically increases their risk of depression or anxiety, a new study says.” According to the study, “nearly 56% of Americans have encountered discrimination in their lives, and almost 4% said they’d experienced high levels of discrimination.” Additionally, results show that “those exposed to high levels of discrimination are five times more likely to be diagnosed with depression or anxiety, and nearly nine times more likely to screen positive for both mood disorders.” Discrimination was most common among Black Americans, multiracial people, “women, immigrants and people with disabilities or obesity, researchers said.” Researchers concluded, “Our results are a powerful reminder that discrimination is everyone’s issue – and addressing it benefits society as a whole.” The study was published in JAMA Network Open.

Related Links:

— “Discrimination Dramatically Increases Risk for Depression, Anxiety,”Dennis Thompson, HealthDay, April 4, 2025

Extended Screen Time Tied To Poor Sleep Quality In Teens, With Depression Symptoms More Common In Girls, Study Finds

HealthDay (4/3, Thompson ) reports a study found that “teenagers who spend more time on screens tend to get worse sleep, both in terms of sleep quality and duration.” While screen time “caused teens to put off sleep until later hours, affecting their wake/sleep cycles,” sleep disturbances are only linked to “later depression symptoms in girls,” but not boys. Specifically, “depression symptoms among girls were more than twice those of boys, a gender difference that’s been found in earlier studies, researchers reported. Results also showed that 38% to 57% of girls’ depression symptoms could be explained by changes in sleep patterns driven by screen use.” Researchers concluded, “The public health recommendation to promote sleep by means of changing screen-related behaviors is…supported by this study.” The study was published in PLOS Global Public Health.

Related Links:

— “Screen Time Linked To Poor Sleep, Depression Among Teen Girls,”Dennis Thompson, HealthDay, April 3, 2025

Enrollment in ACA exchanges has more than doubled over past several years

Fierce Healthcare (4/2, Minemyer ) reports, “Enrollment on the Affordable Care Act’s exchanges has more than doubled over the past several years, with much of that growth coming from red states, according to a new report.” KFF “analysts…found that enrollment in marketplace plans reached 24.3 million for 2025, up from 11.4 million in 2020,” which is “growth of 113% for those five years, the researchers said.”

Related Links:

— “ ACA exchange enrollment has skyrocketed since 2020, with most of the growth in red states: KFF,”Paige Minemyer, Fierce Healthcare, April 2, 2025

Hormonal Contraceptives Linked With Higher Postpartum Depression Risk Among First-Time Mothers, Study Suggests

Psychiatric News (4/2) reports a study suggests that “starting most hormonal contraceptives in the first year postpartum may raise the risk of depression even among first-time mothers with no recent history of the disorder.” Researchers determined there was “a 49% higher risk of depression among hormonal contraceptive users compared with nonusers, after adjusting for factors.” Moreover, the “prevalence of postpartum depression was 1.54% among all women, which the researchers calculated would have been 1.36% had no one taken contraceptives.” The risk also “varied by type of hormonal contraceptive: Compared with nonuse, levonorgestrel-releasing IUDs raised risk of depression by 27% during the study period, progestogen-only nonoral contraceptives by 40%, combined-hormone pills by 72%, and combined-hormonepatches and vaginal rings by 97%.” The study was published in JAMA Network Open.

Related Links:

— “Taking Hormonal Contraception Postpartum May Raise Risk of Depression, Psychiatric News, April 2, 2025

Shingles Vaccine Tied To Decreased Dementia Risk, Study Finds

The New York Times (4/2, Belluck ) reports a study published in Nature “found that people who received the shingles vaccine were 20 percent less likely to develop dementia in the seven years afterward than those who were not vaccinated.” Compared to prior studies suggesting that shingles vaccinations might reduce dementia risk, this study was able to rule out “other dementia-protective characteristics, like healthier lifestyles, better diets or more years of education.” Overall, the results “provide some of the strongest evidence yet that some viral infections can have effects on brain function years later and that preventing them can help stave off cognitive decline.”

The AP (4/2, Neergaard ) reports the study “tracked people in Wales who were around 80 when receiving the world’s first-generation shingles vaccine over a decade ago.”

NBC News (4/2, Carroll ) reports that the “most important take-home message” from the study “is that getting vaccinated might lower the risk for dementia.” It is also possible “that the Food and Drug Administration could review research linking shingles vaccines to a lower risk of dementia and allow the drug company to add that indication to the label,” experts said.

Related Links:

— “The New York Times (requires login and subscription)

Psychostimulant Involvement In Synthetic Opioid Overdose Deaths More Common Among People With Physically Demanding Jobs, Study Suggests

HealthDay (4/1, Gotkine ) reports a study suggests that “a higher percentage of individuals who have psychostimulant involvement in synthetic opioid overdose deaths tend to work in physically demanding occupations and industries.” Researchers found that the “highest percentages of synthetic opioid overdose deaths co-involving psychostimulants with abuse potential (psychostimulants) occurred in occupation and industry groups that were typically physically demanding (e.g., construction and extraction occupations), while the highest percentages of cocaine co-involvement were seen in industries that were generally less physically strenuous (e.g., business and financial occupations).” They concluded, “These hypothesis-generating findings warrant confirmation but point to a potential role for work-related substance use and overdose prevention interventions.” The study was published in the CDC’s Morbidity and Mortality Weekly Report.

Related Links:

— “Stimulant Involvement in Opioid OD Death Higher for Those in Physically Demanding Jobs,”Elana Gotkine, HealthDay, April 1, 2025

One-Fourth Of US Adults Aged 18 To 64 Report Misusing Prescription Stimulants, Study Finds

HealthDay (4/1, Gotkine ) reports that a study found that “the prevalence of prescription stimulant misuse and prescription stimulant use disorder (PSUD) is high among U.S. adults aged 18 to 64 years.” Researchers from the NIH observed “that 25.3 percent of those using prescription stimulants reported misuse and 9.0 percent had PSUD. Among those with PSUD, 72.9, 87.1, 42.5, and 63.6 percent solely used their own prescribed stimulants, used amphetamines, reported no misuse, and had mild PSUD, respectively.” Additionally, the study shows “women aged 35 to 64 years had the largest increase in the number of individuals dispensed prescription stimulants, from 1.2 million in quarter 1 of 2019 to 1.7 million in quarter 4 of 2022.” However, the “prevalence of prescription stimulant misuse was lower among women aged 35 to 64 years using these medications.” The study was published in JAMA Psychiatry.

Related Links:

— “Prevalence of Prescription Stimulant Misuse High in U.S. Adults,”Elana Gotkine, HealthDay, April 1, 2025

Avoidable Deaths Rose In US, Slowed Globally From 2009 To 2019, Study Finds

The Washington Post (3/31) reports a recent study published in JAMA found that “from 2009 to 2019, avoidable mortality increased by an average of 33 deaths per 100,000 people across the United States.” In contrast, avoidable deaths “dropped by an average of nearly 23 deaths per 100,000 across all other countries in the study” during the same period, with European Union countries reducing avoidable deaths by an average of 25 per 100,000. The study noted significant state-by-state variations within the US, “ranging from five avoidable deaths in New York to 100 per 100,000 in West Virginia.” The rise in US deaths was primarily attributed to “external causes such as traffic accidents, homicides, suicides, and drugs and alcohol. Among external causes, drug-related deaths were responsible for 71 percent of the increase in avoidable deaths.” The study also observed a spike in avoidable mortality numbers from 2019 to 2021 across all examined regions, largely due to COVID-19.

Related Links:

— “The Washington Post (requires login and subscription)

Increased Discrimination Exposure Associated With Higher Depression, Anxiety Risk, With Marginalized Groups Affected More Severely, Study Finds

HCPlive (3/31, Derman) reports, “A cross-sectional study found an association between discrimination and mental health across US adults.” About 31% of US adults have experienced at least one major incident of discrimination in their lifetime, with 63% facing discrimination daily. Marginalized groups “experienced more health issues linked to discrimination.” Researchers found that “depression rates rose from 10% to 23% in women and 5.5% to 22% in men (2013–2023). Anxiety rates increased from 8% to 31% in women and 5% to 24% in men (2018–2023). Among Black adults, depression rose from 9% in 2013 to 21% in 2023, while anxiety jumped from 6% in 2018 to 27% in 2023.” Although the study results “demonstrate that White adults experienced higher odds of positive screening results for depression with increasing levels of discrimination,”researchers concluded the finding “does not imply that exposure to discrimination is less significant for Asian, Black, Hispanic or Latino, and other racial and ethnic populations.” The study was published in JAMA Network Open.

Related Links:

— “Daily Discrimination’s Link to Depression, Anxiety Varies by Race,”Chelsie Derman, HCPlive, March 31, 2025